Skip to Content

Cancer Webcast Focuses on Personalized Medicine

August 26, 2009


For archives of this program, please see:
William Pao, M.D., Ph.D., and Jeffrey Sosman, M.D.

William Pao, M.D., Ph.D., Ingram Associate Professor of Cancer Research, and Jeffrey Sosman, M.D., professor of Medicine, will give an update on Vanderbilt-Ingram Cancer Center’s personalized medicine initiatives during a Patient Power Webcast, Tuesday, Aug. 25, 6 – 7 p.m.

Pao is leading development of VICC’s clinical application of “personalized oncology” as well as a national clinical trial studying why some people who never smoke develop lung cancer.

Sosman is a renal cancer expert and director of the VICC Melanoma Program. He will be the national leader of a multi-center Phase II study of an investigational drug for melanoma.

Personalized medicine in cancer includes the use of genetic testing to determine the molecular makeup of a tumor. This enables physicians to match the patient with the best treatment and potentially spares patients from undergoing treatments that may not work.

The Patient Power Webcast will be hosted by leukemia survivor Andrew Schorr. Schorr and his wife launched the online Patient Power program to help patients and families find the best medicine for their condition and return to health.

Listeners are encouraged to call in or e-mail their questions during the live online webcast at The show will be archived later on that site, as well as and